| Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis (NCT02885233) | Oregon Health and Science University | 2017-02-15 |
| Online Program to Reduce Depression in MS (NCT02740361) | Charite University, Berlin, Germany | 2017-02-15 |
| Scan-Rescan Sub-Study of MS PATHS (NCT04123353) | Biogen | 2017-02-11 |
| MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS) (NCT02949908) | Merck KGaA, Darmstadt, Germany | 2017-02-09 |
| Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS) (NCT03049969) | NYU Langone Health | 2017-02-07 |
| Qigong for Multiple Sclerosis: A Feasibility Study (NCT04585659) | National University of Natural Medicine | 2017-02-01 |
| Carnosine Loading and Periodized Training in MS and HC (NCT03418376) | Hasselt University | 2017-02-01 |
| From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical Findings (NCT03108950) | University of Alabama at Birmingham | 2017-02-01 |
| Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance (NCT03052595) | Slovak Academy of Sciences | 2017-02-01 |
| Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis (NCT03032601) | Thomas Jefferson University | 2017-01-05 |
| Muscle Vibration in MS to Improve Walking (NCT03403413) | VA Office of Research and Development | 2017-01-01 |
| Baseline Cortical Haemodynamics in MS (NCT02481882) | University of Nottingham | 2017-01-01 |
| Validation and Standardization of Paramagnetic Rim Lesion (PRL) Identification in Multiple Sclerosis Across MAGNIMS Centers (NCT07705581) | IRCCS San Raffaele | 2017-01-01 |
| Benefits Evaluation of Selfia® Adapted Underwear for MS Patients Performing Self-catheterization (NCT02889419) | Lille Catholic University | 2017-01-01 |
| The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis (NCT03172741) | Colorado State University | 2017-01-01 |
| Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response (NCT04082260) | University Hospital Muenster | 2017-01-01 |
| Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/) (NCT02992847) | Hospices Civils de Lyon | 2017-01-01 |
| Safety of Switching From Rituximab to Ocrelizumab in MS Patients (NCT02980042) | University of Colorado, Denver | 2017-01-01 |
| The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients (NCT03193086) | Glostrup University Hospital, Copenhagen | 2017-01-01 |
| Study of Utilization Patterns of Dimethyl Fumarate in Germany (NCT02969304) | Biogen | 2016-12-30 |
| Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses (NCT03021317) | University of Chicago | 2016-12-20 |
| 3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions (NCT02896647) | Fondation Ophtalmologique Adolphe de Rothschild | 2016-12-14 |
| Study of Biomarkers of the Response to Biotine (NCT03215433) | Centre Hospitalier Universitaire Dijon | 2016-12-08 |
| Prospective Investigation of Multiple Sclerosis in the Three Rivers Region (NCT02994121) | University of Pittsburgh | 2016-12-01 |
| Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis (NCT02966808) | Hospital General Universitario Gregorio Marañon | 2016-12-01 |
| Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) (NCT02936037) | MedDay Pharmaceuticals SA | 2016-12-01 |
| Multiple Sclerosis and Pilates (NCT03006900) | University of Saskatchewan | 2016-12-01 |
| Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study (NCT02952911) | Hoffmann-La Roche | 2016-11-28 |
| Towards Personalized Dosing of Natalizumab in Multiple Sclerosis (NCT03516526) | Amsterdam UMC, location VUmc | 2016-11-03 |
| Pilot Diet Study for Multiple Sclerosis (NCT02986893) | Icahn School of Medicine at Mount Sinai | 2016-11-01 |
| Virtual Reality and Robot Assisted Gait Training in Patients With Multiple Sclerosis (NCT02896179) | Universita di Verona | 2016-11-01 |
| Effect of Video Game Based Physical Activity Training in Persons With Multiple Sclerosis (NCT03045380) | Dokuz Eylul University | 2016-11-01 |
| Remediation of Emotional Processing Deficits in MS (NCT03373344) | Kessler Foundation | 2016-11-01 |
| A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis (NCT02601885) | AbbVie | 2016-10-18 |
| Cognitive-motor Interference in Persons With MS (NCT04158063) | Hasselt University | 2016-10-10 |
| Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques (NCT02784210) | National Institute of Neurological Disorders and Stroke (NINDS) | 2016-10-05 |
| Follow-up of Persons With Multiple Sclerosis (NCT03878836) | Dokuz Eylul University | 2016-10-01 |
| Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS (NCT02965170) | Rocky Mountain MS Research Group, LLC | 2016-10-01 |
| Physical Telerehabilitation in Multiple Sclerosis (NCT03230903) | Columbia University | 2016-10-01 |
| Plantar Pressure Distribution in Patient With Multiple Sclerosis (NCT02947906) | Hacettepe University | 2016-10-01 |
| Correlation Between PET and Advanced MRI in Multiple Sclerosis (NCT02869360) | University of British Columbia | 2016-10-01 |
| Integrating Caregiver Support Into MS Care (NCT02835677) | VA Office of Research and Development | 2016-09-07 |
| Feasibility and Reliability of Multimodal Evoked Potentials (NCT03686826) | University Hospital, Basel, Switzerland | 2016-09-06 |
| Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis (NCT02898974) | Colorado State University | 2016-09-01 |
| Endurance and Walking Training by Nordic Walking in Multiple Sclerosis (NCT03976128) | Multiple Sclerosis Center of Catalonia | 2016-09-01 |
| Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis (NCT02880553) | Fondation Ophtalmologique Adolphe de Rothschild | 2016-08-23 |
| Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis (NCT02466074) | The University of Texas Health Science Center, Houston | 2016-08-17 |
| Testing a Resilience Intervention for Individuals Aging With Multiple Sclerosis (MS) (NCT03177785) | University of Washington | 2016-08-04 |
| Comparison of Two Physical Activity Interventions in Individuals With Multiple Sclerosis (NCT02496416) | Kessler Foundation | 2016-08-01 |
| The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Patients (NCT02848898) | Federico II University | 2016-08-01 |
| Effect of Active-Passive Trainer Cycling on Multiple Sclerosis (NCT02737904) | NHS Greater Glasgow and Clyde | 2016-08-01 |
| A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS) (NCT02846558) | Johns Hopkins University | 2016-08-01 |
| Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study (NCT02914964) | Terry L. Wahls | 2016-08-01 |
| Comparison of Two Different Virtual Reality Methods in Patients With Multiple Sclerosis (NCT03436927) | Biruni University | 2016-07-15 |
| Reliability and Validity Studies of Turkish Version of Manual Ability Measure-36 (NCT06122740) | Istanbul Medeniyet University | 2016-07-15 |
| Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients (NCT02664623) | Centre Hospitalier Universitaire de Nīmes | 2016-07-13 |
| To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS (NCT02869425) | RVL Pharmaceuticals, Inc. | 2016-07-01 |
| Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. (NCT02750982) | Brown, Theodore R., M.D., MPH | 2016-07-01 |
| Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis. (NCT03069170) | Stem Cells Arabia | 2016-07-01 |
| Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes (NCT02833142) | Biogen | 2016-07-01 |
| Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS (NCT02797015) | Celgene | 2016-06-23 |
| The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients (NCT03150966) | Tabriz University of Medical Sciences | 2016-06-08 |
| Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study (NCT02760056) | Oregon Health and Science University | 2016-06-06 |
| Effects of Stimulation Patterns of Deep Brain Stimulation (NCT02553525) | Duke University | 2016-06-02 |
| Timing of Acute Palliative Care Consultation in Critically Ill Patients (NCT02858778) | Wayne State University | 2016-06-01 |
| Swiss Multiple Sclerosis Registry (NCT02980640) | Swiss Multiple Sclerosis Registry | 2016-06-01 |
| Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients (NCT02876536) | Isfahan University of Medical Sciences | 2016-06-01 |
| Treating Anorectal Dysfunction in MS (NCT02609607) | David Levinthal | 2016-06-01 |
| Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS (NCT02446886) | Weill Medical College of Cornell University | 2016-06-01 |
| How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis? (NCT02870023) | University of Aarhus | 2016-06-01 |
| Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (NCT02738775) | TG Therapeutics, Inc. | 2016-05-27 |
| Adderall XR and Cognitive Impairment in MS (NCT02676739) | Sarah Morrow | 2016-05-20 |
| A Phase 1 Study of ARN-6039 (NCT03237832) | Arrien Pharmaceuticals | 2016-05-16 |
| EPID Multiple Sclerosis Pregnancy Study (NCT02749396) | Bayer | 2016-05-02 |
| PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases (NCT02649985) | Brigham and Women's Hospital | 2016-05-02 |
| Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire (NCT03927092) | Ege University | 2016-05-01 |
| Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) (NCT02776072) | Biogen | 2016-05-01 |
| Motor Imagery Training in Persons With Multiple Sclerosis (NCT02781142) | Dokuz Eylul University | 2016-05-01 |
| Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis (NCT04973501) | Charles University, Czech Republic | 2016-05-01 |
| Pathological Basis of MRI Signal Changes in Multiple Sclerosis (NCT02659956) | National Institute of Neurological Disorders and Stroke (NINDS) | 2016-04-07 |
| Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS (NCT02675413) | Washington University School of Medicine | 2016-04-01 |
| Intervention for Employed Women With Multiple Sclerosis (NCT04100525) | Holy Name Medical Center, Inc. | 2016-04-01 |
| Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis (NCT03134716) | Turku University Hospital | 2016-04-01 |
| Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting (NCT03047460) | Clinique Neuro-Outaouais | 2016-04-01 |
| Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis (NCT02759211) | Mount Sinai Rehabilitation Hospital | 2016-04-01 |
| Attention/Working Memory Rehabilitation in Multiple Sclerosis: A Pilot Project Using Cogmed Working Memory Training (NCT02634567) | London Health Sciences Centre | 2016-04-01 |
| Comprehensive Fall Prevention and Detection in Multiple Sclerosis (NCT02583386) | Portland VA Medical Center | 2016-04-01 |
| Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis (NCT01453764) | Ageless Regenerative Institute | 2016-04-01 |
| GTA-MEG as a Biomarker for Cognition in MS (NCT02851342) | Universitair Ziekenhuis Brussel | 2016-04-01 |
| Pilot Study of Transcranial Direct Current Stimulation (tDCS) (NCT02746705) | NYU Langone Health | 2016-04-01 |
| Virtual Reality and Manual Dexterity in in Patients With Multiple Sclerosis (NCT03186612) | Universidad Rey Juan Carlos | 2016-03-02 |
| Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis (NCT02636829) | Centre Hospitalier Universitaire de Nīmes | 2016-03-01 |
| Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training (NCT03057652) | The University of Texas Health Science Center, Houston | 2016-03-01 |
| Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy (NCT02525367) | Amsterdam UMC, location VUmc | 2016-03-01 |
| Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis (NCT02493166) | Hasselt University | 2016-03-01 |
| Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis (NCT02671682) | Albert Christian Ludolph, Prof. | 2016-02-26 |
| Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple Sclerosis (NCT02805634) | Brugmann University Hospital | 2016-02-09 |
| Tecfidera and MRI for Brain Energy in MS (NCT02644083) | Oregon Health and Science University | 2016-02-01 |
| Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis (NCT03122873) | Mayo Clinic | 2016-02-01 |
| Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants (NCT02641041) | Biogen | 2016-02-01 |